Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: second revenue stream in the bag ??

Ohhhhh, there's that puzzle piece I've been looking for. Very interesting point and good info. Thanks for the help. The company itself wouldn't have enough bought back to make the 8%. We'll have to wait for the next proxy to see.

Also, here's something I pulled out of the last 10-K (it's a little different than 16,000),

  On August 9, 2007 the closing price of our stock was $0.49 and we had approximately 607 shareholders of record. Because most of our common stock is held by brokers and other institutions on behalf of stockholders, we are unable to estimate the total number of beneficial owners represented by these record holders.

Share
New Message
Please login to post a reply